NCT05792306

Brief Summary

The purpose of this study is to test whether the reduction of the sense of discomfort and redness and swelling of the skin surrounding the wound of patients by use of the novel electrolyzed water spray will relieve the inflammation of the skin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 29, 2023

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

February 27, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 31, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2023

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2024

Completed
Last Updated

April 25, 2024

Status Verified

February 1, 2023

Enrollment Period

6 months

First QC Date

February 27, 2023

Last Update Submit

April 24, 2024

Conditions

Keywords

Electrolyzed water deviceHydroxyl radicalTap waterSprayLaser surgery woundDiscomfort of the skinRedness of the skin

Outcome Measures

Primary Outcomes (1)

  • The sense of discomfort scale made by the Numeric Pain Rating Scale (NPRS).

    This score is based on descriptions of the discomfort of the skin surrounding the wound that patients rate 0-10 to assess the condition of their skin. A higher score means a worse outcome. 0 means "no discomfort " and 10 means "the most discomfort ".

    1 hour

Secondary Outcomes (1)

  • A skin signs scale made by modifying the Numeric Pain Rating Scale (NPRS).

    3 hour

Study Arms (2)

The electrolyzed water spray group

EXPERIMENTAL

Study staff will use the novel electrolyzed water spray device and spray for approximately 2-4 minutes on the participant's diseased area until half a bottle (20-40ml) of water is used.

Device: The novel electrolyzed water spray

Control group of water spray

PLACEBO COMPARATOR

Study staff will use the saline and spray for approximately 2-4 minutes on the participant's diseased area until half a bottle (20-40ml) of water is used.

Device: The saline spray

Interventions

The researcher use electrolyzed water to treat the diseased area, two times a day, for 5 days. The trial consists of 5 study visits (day 1-day 5). The reduction in the disease area of discomfort, redness and swelling evaluation and adverse event assessments will be performed at each visit. Safety analysis will be assessed based on the reports of adverse events during the study.

The electrolyzed water spray group

The researcher use saline to treat the diseased area, two times a day, for 5 days. The trial consists of 5 study visits (day 1-day 5). The reduction in the disease area of discomfort, redness and swelling evaluation and adverse event assessments will be performed at each visit. Safety analysis will be assessed based on the reports of adverse events during the study.

Control group of water spray

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mild discomfort, redness and swelling of the skin surrounding the wound created by skin laser surgery
  • Patient \> 18 years old.

You may not qualify if:

  • Severe discomfort, redness and swelling of the skin surrounding the wound created by skin laser surgery.
  • years or older.
  • Pregnant or breastfeeding women
  • Systemically healthy individuals.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Huinuode Biotechnology Co., Ltd.

Qingdao, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: An open label, two arm clinical study
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2023

First Posted

March 31, 2023

Study Start

January 29, 2023

Primary Completion

July 15, 2023

Study Completion

March 10, 2024

Last Updated

April 25, 2024

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share
Shared Documents
CSR
Time Frame
until publication of this clinical study and international patent granted

Locations